Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Nov 2 2021

Full Issue

Judge Rejects California Bid To Hold Drugmakers Liable For Opioid Crisis

Bucking trends in other legal cases, Superior Court Judge Peter Wilson issued a tentative ruling that could free four major pharmaceutical companies from legal responsibility for the painkiller addiction epidemic in parts of California.

Stat: In A First, A California Judge Rules Drug Makers Are Not Liable For The Opioid Crisis

For the first time, drug makers won a court victory in the massive litigation over the opioid epidemic, defeating local governments in California that claimed the company created a public health crisis through misleading marketing of the prescription painkillers. In a tentative decision on Monday, Superior Court Judge Peter Wilson rejected arguments that Teva Pharmaceuticals, Johnson & Johnson, AbbVie, and Endo International had deceived the public about the addictive risks of the opioids, promoted them for unintended uses, and encouraged overprescribing by physicians. (Silverman, 11/1)

NPR: A California Court Says Drug Companies Aren't Liable For The State's Opioid Crisis

The companies denied any wrongdoing. If found liable, they would likely have been forced to pay for a wide range of costly public health and drug treatment programs. In his 41-page ruling, however, Judge Peter J. Wilson said it was unclear the drug industry's marketing efforts led to directly to a rise in illegal use of prescription opioid painkillers. "The Court finds that plaintiffs have failed to prove an actionable public nuisance for which defendants, or any of them, are legally liable," Wilson concluded. (Mann, 11/1)

Bloomberg: J&J, Teva Beat $50 Billion Opioid Case In First Industry Win

Officials in Los Angeles, Santa Clara and Orange counties and the city of Oakland sought as much as $50 billion to beef up policing and treatment budges depleted by the epidemic. It’s the first time a judge or jury has rejected claims by states or local governments that ex-opioid makers should be held liable for the fallout from the U.S. opioid epidemic, which has claimed the lives of almost 500,000 Americans over the last two decades. (Feeley, 11/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF